88 Epizód

  1. Premysl Bercik on a double-blind crossover trial of gluten and wheat in IBS

    Közzétéve: 2025. 11. 20.

  2. Julia Mayerle on the validation of plasma multimetabolite signatures for patients at risk of or with suspected pancreatic ductal adenocarcinoma

    Közzétéve: 2025. 06. 19.

  3. Salvatore Piano on the global epidemiology of acute kidney injury in hospitalised patients with decompensated cirrhosis

    Közzétéve: 2025. 04. 09.

  4. John Chia on the ASCOLT trial of adjuvant aspirin for colorectal cancer

    Közzétéve: 2025. 03. 06.

  5. Hannes Hagström on screening for advanced liver fibrosis alongside retina scanning in people with type 2 diabetes

    Közzétéve: 2025. 01. 10.

  6. Cathy Lu on intestinal ultrasound for assessing and monitoring Crohn's disease small bowel strictures

    Közzétéve: 2024. 12. 12.

  7. Peter De Cruz on the PREDICT-UC trial of intensified versus standard dose infliximab for steroid-refractory acute severe ulcerative colitis

    Közzétéve: 2024. 11. 06.

  8. Shahida Din and Beatriz Gros on the harms associated with receiving placebo in trials of drugs for inflammatory bowel disease

    Közzétéve: 2024. 11. 01.

  9. Arndt Vogel on the NALIRICC trial of nanoliposomal irinotecan in pretreated advanced biliary tract cancer

    Közzétéve: 2024. 07. 31.

  10. Nancy Baxter on the duration of colorectal cancer risk reduction with a complete colonoscopy

    Közzétéve: 2024. 07. 01.

  11. Sanna Nybacka and Magnus Simrén on a trial of low FODMAP diets versus low carbohydrate diets in IBS

    Közzétéve: 2024. 05. 17.

  12. Nuru Noor on the PROFILE trial of biomarker-stratified treatment in newly diagnosed Crohn's disease

    Közzétéve: 2024. 05. 07.

  13. Yusuke Shimakawa on a simple score for hepatitis B treatment eligibility in Africa

    Közzétéve: 2024. 04. 22.

  14. Mads Israelsen on validating the new steatotic liver disease nomenclature in people with excessive alcohol intake

    Közzétéve: 2024. 03. 12.

  15. Louise Dye on the role of expectancy and gluten in non-coeliac gluten sensitivity

    Közzétéve: 2024. 03. 01.

  16. Tzu-Chan Hong on the primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region

    Közzétéve: 2023. 12. 19.

  17. Sarah Moen on metachronous colorectal cancer risk according to Lynch syndrome pathogenic variant after colectomy

    Közzétéve: 2023. 11. 29.

  18. Anna Emilie Kann on the causes of mortality in patients with alcohol-related liver disease

    Közzétéve: 2023. 10. 12.

  19. Robert Krouse on surgical versus non-surgical management of malignant bowel obstruction

    Közzétéve: 2023. 09. 13.

  20. Marc Rothenberg on a trial of benralizumab in eosinophilic gastritis

    Közzétéve: 2023. 08. 10.

1 / 5

Hugh Thomas, Deputy Editor at The Lancet Gastroenterology & Hepatology, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from predicting clinical outcomes in NAFLD to immunosuppressant withdrawal in patients with Crohn’s disease, the primary antibiotic resistance of Helicobacter pylori to surgical versus non-surgical management of malignant bowel obstruction, and more.

Visit the podcast's native language site